🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you ACIR as always for the amazing summary!

BSG-MSRP-Bio student Yeongseo Son breathed new life into her love of science over a summer of studying immune responses in the lungs in the Spranger Lab Stefani Spranger biology.mit.edu/bsg-msrp-bio-s…

👏Congrats to RSNA resident grant awardees 🔥Amy Wisdom, MD, PhD for novel #glioblastoma mouse models Stefani Spranger Koch Institute at MIT Massachusetts Institute of Technology (MIT) 🔥Ismael Banla, MD PhD for novel radiation induced payload releases William L Hwang @MGH_RI Broad Institute Excited for what you will accomplish‼️

It was great to have Kay MacLeod here at the Koch Institute at MIT and MIT Science today as part of our 50th anniversary of the cancer center! Kay was Jacks Lab first postdoc in 1993 and is now professor UniversityofChicago Cancer center!

New #JITC article: Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression bit.ly/4ejyxSZ Malte Roerden Kevin Litchfield Stefani Spranger #SITC24

So fun to have Scott Lowe Lowe Lab visit Koch Institute at MIT for our 50th anniversary seminar series.

Thank you Journal for ImmunoTherapy of Cancer for the nice summary! It shows nicely how different combinations of cross-presented antigens affect anti-tumor immunity and immune evasion.

Very excited to share our recent work now published in Nature Rev Immunol! We reviewed how immune evasion mechanisms interfere with immunoediting to fosters intratumor heterogeneity (ITH) and discuss data on the role of ITH itself in blunting anti-tumor immunity. Stefani Spranger

How different immune evasion mechanisms interfere with immunoediting of evolving tumors - Malte Roerden Stefani Spranger Nature Rev Immunol oncodaily.com/url/218440 #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Would love to see many of you at #KSCancerImmune25 at Fairmont Banff Springs, I am co-organizing together with Stefani Spranger & Christian Blank, held jointly with Immune Cell Therapies. keystonesymposia.org/conferences/co…

Looking forward to the visit!

Meet the Author: Malte Roerden (Malte Roerden), a physician-scientist from Koch Institute at MIT, is 1st author of “Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression,” recently published in #JITC! 1/6

Review Science Immunology Vidit Bhandarkar Stefani Spranger DC–T cell interactions during priming influence CD8+ T cell fate, and DCs subsequently sustain T cell responses against cancer science.org/doi/10.1126/sc…

A new Science #Immunology Review discusses the mechanisms through which #DendriticCells influence cytotoxic CD8+ #TCell responses against cancer. Vidit Bhandarkar Stefani Spranger scim.ag/4haL9hg